12-104304149-A-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001008394.3(EID3):c.215A>T(p.Glu72Val) variant causes a missense change. The variant allele was found at a frequency of 0.0022 in 1,613,914 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E72K) has been classified as Uncertain significance.
Frequency
Consequence
NM_001008394.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EID3 | NM_001008394.3 | c.215A>T | p.Glu72Val | missense_variant | 1/1 | ENST00000527879.2 | |
TXNRD1 | NM_001093771.3 | c.415-7141A>T | intron_variant | ENST00000525566.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EID3 | ENST00000527879.2 | c.215A>T | p.Glu72Val | missense_variant | 1/1 | NM_001008394.3 | P1 | ||
TXNRD1 | ENST00000525566.6 | c.415-7141A>T | intron_variant | 1 | NM_001093771.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00102 AC: 156AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000842 AC: 210AN: 249286Hom.: 0 AF XY: 0.000939 AC XY: 127AN XY: 135242
GnomAD4 exome AF: 0.00232 AC: 3387AN: 1461708Hom.: 8 Cov.: 30 AF XY: 0.00223 AC XY: 1621AN XY: 727134
GnomAD4 genome AF: 0.00102 AC: 156AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.000766 AC XY: 57AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.215A>T (p.E72V) alteration is located in exon 1 (coding exon 1) of the EID3 gene. This alteration results from a A to T substitution at nucleotide position 215, causing the glutamic acid (E) at amino acid position 72 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at